In the event of intolerable side effects or failure of treatment, other immunosuppressants may be used, most commonly Imuran. Patients with myasthenia gravis, especially untreated ... including ...

Opens in a new tab or window Heightened focus on delays in diagnosing generalized myasthenia gravis ... like myasthenic crisis or respiratory failure due to severe respiratory muscle weakness.

Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).